drugset / Trial / NCT06656442
"The Effect of Trimetazidine on the Clinical Outcome of Acute Ischemic Stroke Patients"
RandomizedParallel-groupSingle-blindTreatment
Summary
The investigators need to test the effect of Trimetazidine on the pro-inflammatory marker Interleukin - 18 , NIHSS score, and mRs score of acute ischemic stroke patients.
Timeline
- Start
- 2024-09-01
- Primary completion
- 2025-02-28
- Completion
- 2025-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Trimetazidine | Small molecule | 35 mg | — |